Fair Value (Tables)

9 Months Ended

Sep. 26, 2015

Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis

Assets, liabilities, and noncontrolling interest measured at fair value on a recurring basis are summarized below:



	September 26, 2015
	Level 1		Level 2		Level 3		Total
	(in thousands)
Cash equivalents	$	—	$	159	$	—	$	159
Other current assets:
Marketable securities	4,570		—		—		4,570
Foreign currency forward contracts	—		16		—		16
Other assets:
Life insurance policies	—		19,346		—		19,346
Total assets measured at fair value	$	4,570	$	19,521	$	—	$	24,091

Other current liabilities:
Contingent consideration	$	—	$	—	$	1,111	$	1,111
Foreign currency forward contracts	—		306		—		306
Other long-term liabilities:
Contingent consideration	—		—		169		169
Redeemable noncontrolling interest	—		—		27,447		27,447
Total liabilities and redeemable noncontrolling interest measured at fair value	$	—	$	306	$	28,727	$	29,033



	December 27, 2014
	Level 1		Level 2		Level 3		Total
	(in thousands)
Cash equivalents	$	—	$	1,934	$	—	$	1,934
Other assets:
Life insurance policies	—		20,520		—		20,520
Total assets measured at fair value	$	—	$	22,454	$	—	$	22,454

Other current liabilities:
Contingent consideration	$	—	$	—	$	1,583	$	1,583
Other long-term liabilities:
Contingent consideration	—		—		1,245		1,245
Redeemable noncontrolling interest	—		—		28,419		28,419
Total liabilities and redeemable noncontrolling interest measured at fair value	$	—	$	—	$	31,247	$	31,247

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

The following table provides a rollforward of the fair value of the Company’s redeemable noncontrolling interest:



	Nine Months Ended
	September 26, 2015			September 27, 2014
	(in thousands)
Beginning balance	$	28,419		$	20,581
Additions	—			—
Total gains or losses (realized/unrealized):
Net income attributable to noncontrolling interest	614			523
Foreign currency translation	(693		)	(113		)
Change in fair value, included in additional paid-in capital	(893		)	3,559
Ending balance	$	27,447		$	24,550

Fair Value, Contingent Consideration

The following table provides a rollforward of the contingent consideration related to the acquisitions of Argenta, BioFocus, VivoPath and ChanTest. See Note 2, “Business Acquisitions.”



	Nine Months Ended
	September 26, 2015			September 27, 2014
	(in thousands)
Beginning balance	$	2,828		$	—
Additions	675			2,428
Payments	(600		)	—
Total gains or losses (realized/unrealized):
Reversal of previously recorded contingent liability and change in fair value	(1,623		)	120
Ending balance	$	1,280		$	2,548